1. Home
  2. Antibiotic use in poultry sector rampant: CSE

Antibiotic use in poultry sector rampant: CSE

Agencies
February 28, 2018

New Delhi, Feb 28: A green body has slammed an advertisement highlighting that no antibiotics are used in chicken as an "eye wash" and alleged that the use of antibiotics in poultry sector is "rampant". The Centre for Science and Environment (CSE) yesterday slammed the All India Poultry Development and Services Private Limited for its advertisement and said it was "complete misrepresentation". The advertisement refers to the results of a 2014 study conducted by the CSE on chicken, it said while strongly rejecting the way the study results have been twisted to suggest that there is no misuse of antibiotics in the poultry sector and that the chicken produced is safe. "This is complete misrepresentation of the facts and the antibiotic misuse practices adopted by the Indian poultry industry. Antibiotic use in poultry sector is rampant. "They are even using life-saving drugs like colistin to fatten the chicken. There seem to be no genuine attempt by the industry to reduce antibiotic misuse and this advertisement is an eyewash,? the Deputy Director General, CSE, Chandra Bhushan, said.

The advertisement which said that chicken should be eaten as it has a lot of benefits, also went on to say that the Indian poultry industry has already adopted usage of prebiotics, probiotics, phytogenic additives, acidifiers and immuno stimulants as an alternative to antibiotics. The deputy director general of CSE further said that the industry has ignored the results of its latest 2017 study, which show how poultry farms are breeding grounds of superbugs. "They are misguiding the nation and trying to dilute their contribution to the problem of antibiotic resistance. This will not help the industry in the long-term. They must act responsibly,? Bhushan said. Referring to the issue of maximum residue limits (MRLs) in the advertisement, Amit Khurana, a senior programme manager, Food Safety and Toxins team, CSE said that it is a "myopic" view as residue level in food is only one part of the problem. "Resistant bacteria can also get transferred to handlers and consumers. Unabsorbed antibiotics as well as resistant bacteria in chicken droppings which enter into the environment are a big concern. The problem starts with antibiotic misuse," he said.

Chandra Bhushan further added that India does not have any standards on residue levels in chicken meat. "Comparing residue results with the MRL of the European Union is meaningless. Our study was aimed at establishing the fact that banned, critical and highly prescribed antibiotics are being misused by the poultry industry ? we did not make any comparisons with MRL as India does not have an MRL of its own," Bhushan said. CSE researchers believe that even after so many years of the issue being highlighted, the government response to address the antibiotic resistance crisis has been inadequate so far. "There is no legal ban on use of antibiotic growth promoters in poultry. The 2014 advisory from the Department of Animal Husbandry, Dairying and Fisheries has no legal binding. "The Food Safety and Standards Authority of India is yet to come up with final standards of antibiotic residues in chicken. We have a National Action Plan on AMR now, but unfortunately there are no funds allocated for it. The plan would have no real functionality without money put behind it," Bhushan added.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 5,2020

Washington D.C., Jan 5: After a woman filed a lawsuit against a diet soda company, the California court has declared that the beverage does not promise to help buyers in losing weight.

The woman had gulped down the drink for over a decade but did not lose inches as a result.

The three-judge panel declared during the hearing: "The prevalent understanding of the term in (the marketplace) is that the 'diet' version of a soft drink has fewer calories than its 'regular' counterpart."

However, the members of the US 9th circuit court have felt that the consumers tend to make out something of their own that is unreasonable and eventually hamper the reputation of brands through a deceptive allegation, reports Fox News.

The response was due to a misleading case filed against Diet Dr Pepper by Shana Becerra from Santa Rosa, California. Shana claimed that she has been addictively purchasing the low-calorie beverage for the past 13 years hoping for losing some fat but failed to lose even a single inch.

The woman also stated that the attractive and fit models misled her into believing that drink will help her in perfecting her body like them.

However, the court's decision was that advertisements are for representational purposes only. "Cannot be reasonably understood to convey any specific meaning at all," as written by Judge Jay Bybee.

Shana had last week made such allegation against Diet coke as well where the court came to a similar verdict. She claimed that she had found various studies where it is evident that the artificial sweetener aspartame used in diet beverages actually boosts weight gain.

But the artificial sweetener is approved in by the concerned administrative department and thus is used in most American drinks.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 23,2020

Los Angeles, Feb 23: According to researchers, if administered quickly, a common medication that reduces bleeding could be a treatment for bleeding stroke.

The Spot Sign and Tranexamic Acid on Preventing ICH Growth - Australasia Trial (STOP-AUST) was a multicenter, prospective, randomized, double-blind, placebo-controlled, phase 2 clinical trial using the antifibrinolytic agent tranexamic acid in people with intracerebral hemorrhage (ICH).

ICH is a severe form of acute stroke with few treatment options.

Tranexamic acid is currently used to treat or prevent excessive blood loss from trauma, surgery, tooth removal, nosebleeds and heavy menstruation. For this study, one hundred patients with active brain bleeding were given either intravenous tranexamic acid or placebo within 4.5 hours of symptom onset.

Researchers analyzed brain CT scans taken during the 24-hour period after treatment with tranexamic acid or placebo.

Researchers found a trend towards reduced hemorrhage expansion in the group treated with tranexamic acid, especially in those treated within 3 hours of the brain bleed. However, this trend was not statistically significant. The finding was consistent with previous research using the medication.

"Further trials using tranexamic acid are ongoing and focusing on ultra-early treatment - within 2 hours. 

This is where the greatest opportunity for intervention appears to be. Tranexamic acid is inexpensive, safe and widely available. Our results and others provide great impetus for further, focused research using this treatment," Nawaf Yassi said.

Larger trials focused on patient outcomes are required for this therapy to enter routine clinical practice.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 7,2020

The World Health Organization (WHO) is reviewing a report that suggested its advice on the novel coronavirus needs updating after some scientists told the New York Times there was evidence the virus could be spread by tiny particles in the air.

The WHO says the Covid-19 disease spreads primarily through small droplets, which are expelled from the nose and mouth when an infected person breaths them out in coughs, sneezes, speech or laughter and quickly sink to the ground.

In an open letter to the Geneva-based agency, 239 scientists in 32 countries outlined the evidence they say shows that smaller exhaled particles can infect people who inhale them, the newspaper said on Saturday.

Because those smaller particles can linger in the air longer, the scientists - who plan to publish their findings in a scientific journal this week - are urging WHO to update its guidance, the Times said.

"We are aware of the article and are reviewing its contents with our technical experts," WHO spokesman Tarik Jasarevic said in an email reply on Monday to a Reuters request for comment.

The extent to which the coronavirus can be spread by the so-called airborne or aerosol route - as opposed to by larger droplets in coughs and sneezes - remains disputed.

Any change in the WHO's assessment of the risk of transmission could affect its current advice on keeping one-metre physical distancing. Governments, which also rely on the agency for guidance policy, may also have to adjust public health measures aimed at curbing the spread of the virus.

"Especially in the last couple of months, we have been stating several times that we consider airborne transmission as possible but certainly not supported by solid or even clear evidence," Benedetta Allegranzi, the WHO's technical lead for infection prevention and control, was quoted as saying in the New York Times.

WHO guidance to health workers, dated June 29, says that SARS-CoV-2, the virus that causes Covid-19, is primarily transmitted between people through respiratory droplets and on surfaces.

But airborne transmission via smaller particles is possible in some circumstances, such as when performing intubation and aerosol-generating procedures, it says.

Medical workers performing such procedures should wear heavy-duty N95 respiratory masks and other protective equipment in an adequately ventilated room, the WHO says.

Officials at South Korea's Centers for Disease Control said on Monday they were continuing to discuss various issues about Covid-19, including the possible airborne transmission. They said more investigations and evidence were needed.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.